Interestingly, LC degeneration correlated better with AD onset and duration than degeneration of the cholinergic nucleus basalis of Meynert (nbM) in the basal forebrain [100, 169], which is also highly vulnerable to tau pathology in AD, indicating that noradrenergic deficits in AD play a major role in disease progression. This evidence concerns the gene MAPT and Alzheimer disease.